SLC31A1 and breast carcinoma: More recently, SLC31A1, a cuproptosis‐related gene, has emerged as a novel breast cancer biomarker with diagnostic and prognostic significance, showing strong upregulation driven by hypomethylation and association with poor survival and immune cell infiltration [69].